Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Invasive lobular breast cancer: subtypes and outcome.

Iorfida M, Maiorano E, Orvieto E, Maisonneuve P, Bottiglieri L, Rotmensz N, Montagna E, Dellapasqua S, Veronesi P, Galimberti V, Luini A, Goldhirsch A, Colleoni M, Viale G.

Breast Cancer Res Treat. 2012 Jun;133(2):713-23. doi: 10.1007/s10549-012-2002-z. Epub 2012 Mar 8.

PMID:
22399188
2.

The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.

Jung SY, Jeong J, Shin SH, Kwon Y, Kim EA, Ko KL, Shin KH, Lee KS, Park IH, Lee S, Kim SW, Kang HS, Ro J.

BMC Cancer. 2010 Dec 3;10:664. doi: 10.1186/1471-2407-10-664.

3.

Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.

Fortunato L, Mascaro A, Poccia I, Andrich R, Amini M, Costarelli L, Cortese G, Farina M, Vitelli C.

Ann Surg Oncol. 2012 Apr;19(4):1107-14. doi: 10.1245/s10434-011-1907-9. Epub 2011 Sep 13.

PMID:
21913022
4.

Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.

Shah C, Wilkinson JB, Shaitelman S, Grills I, Wallace M, Mitchell C, Vicini F.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e547-51. doi: 10.1016/j.ijrobp.2011.04.050. Epub 2011 Jun 2.

PMID:
21640491
6.

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, Robertson JF, Blamey R, Gee J, Nicholson RI, Lee AH, Ellis IO.

Eur J Cancer. 2008 Jan;44(1):73-83. Epub 2007 Nov 26.

PMID:
18035533
7.

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Arpino G, Bardou VJ, Clark GM, Elledge RM.

Breast Cancer Res. 2004;6(3):R149-56. Epub 2004 Feb 17.

8.

Survival analysis between patients with invasive ductal and invasive lobular breast cancer.

Dian D, Herold H, Mylonas I, Scholz C, Janni W, Sommer H, Friese K.

Arch Gynecol Obstet. 2009 Jan;279(1):23-8. doi: 10.1007/s00404-008-0662-z. Epub 2008 May 1.

PMID:
18449551
9.
10.

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.

Adachi Y, Ishiguro J, Kotani H, Hisada T, Ichikawa M, Gondo N, Yoshimura A, Kondo N, Hattori M, Sawaki M, Fujita T, Kikumori T, Yatabe Y, Kodera Y, Iwata H.

BMC Cancer. 2016 Mar 25;16:248. doi: 10.1186/s12885-016-2275-4.

11.

Metaplastic carcinoma of the breast.

Okada N, Hasebe T, Iwasaki M, Tamura N, Akashi-Tanaka S, Hojo T, Shibata T, Sasajima Y, Kanai Y, Kinoshita T.

Hum Pathol. 2010 Jul;41(7):960-70. doi: 10.1016/j.humpath.2009.11.013. Epub 2010 Mar 17.

PMID:
20236684
12.

Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature.

Jacobs M, Fan F, Tawfik O.

Ann Diagn Pathol. 2012 Jun;16(3):185-9. doi: 10.1016/j.anndiagpath.2011.10.001. Epub 2011 Dec 24. Review.

PMID:
22197540
13.

Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.

Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P.

Cancer. 1996 Jan 1;77(1):113-20.

14.

[Subtyping and prognostic assessment of invasive lobular breast carcinoma].

Sinn HP, Kellerhoff NM, Kellerhoff R, Bastert G, Otto HF.

Pathologe. 1997 Jan;18(1):37-44. German.

PMID:
9157403
15.

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes.

Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, Montagna E, Dellapasqua S, Iorfida M, Cardillo A, Veronesi P, Luini A, Intra M, Gentilini O, Scarano E, Goldhirsch A, Colleoni M.

Breast Cancer Res Treat. 2011 Jun;127(3):713-20. doi: 10.1007/s10549-011-1465-7. Epub 2011 Mar 31.

PMID:
21452022
16.

Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.

García-Fernández A, Lain JM, Chabrera C, García Font M, Fraile M, Barco I, Torras M, Reñe A, González S, González C, Piqueras M, Veloso E, Cirera L, Pessarrodona A, Giménez N.

Breast J. 2015 Sep-Oct;21(5):533-7. doi: 10.1111/tbj.12455. Epub 2015 Jul 17.

PMID:
26190560
17.
18.

Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study.

Lee JH, Park S, Park HS, Park BW.

World J Surg Oncol. 2010 Apr 27;8:34. doi: 10.1186/1477-7819-8-34.

19.

Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?

Jayasinghe UW, Bilous AM, Boyages J.

Breast J. 2007 Sep-Oct;13(5):479-85.

PMID:
17760669
20.

A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast.

Korhonen T, Huhtala H, Holli K.

Breast Cancer Res Treat. 2004 May;85(1):23-9.

PMID:
15039595

Supplemental Content

Support Center